Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-03-25

Clinical Trial Update: A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP [Phase 2]

View source ↗

Summary

Sponsored by Cardiometabolics, a Phase 2 trial in higher-risk geriatric patients undergoing OHSP for heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cardiometabolics | Conditions: Heart Disease | Phase 2 | Status: COMPLETED